The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
    1. About this group
    2. Reviews
      1. 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)ReviewDiagnosticNew
      2. Acetyl-l-carnitine for dementiaReview
      3. Acupuncture for vascular dementiaReview
      4. Almitrine-Raubasine combination for dementiaReview
      5. Alpha lipoic acid for dementiaReview
      6. Antidepressants for agitation and psychosis in dementiaReview
      7. Antidepressants for treating depression in dementiaReview
      8. Antipsychotics for deliriumReview
      9. Aromatherapy for dementiaReview
      10. Aspirin for vascular dementiaReview
      11. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseReview
      12. Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseReview
      13. Benzodiazepines for deliriumReview
      14. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaReview
      15. Cannabinoids for the treatment of dementiaReview
      16. Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairmentReview
      17. Cerebrolysin for vascular dementiaReview
      18. Cholinesterase inhibitors for Alzheimer's diseaseReview
      19. Cholinesterase inhibitors for deliriumReview
      20. Cholinesterase inhibitors for dementia with Lewy bodiesReview
      21. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseReviewComment
      22. Cholinesterase inhibitors for mild cognitive impairmentReview
      23. Cholinesterase inhibitors for Parkinson's disease dementiaReview
      24. Cognition-based interventions for healthy older people and people with mild cognitive impairmentReview
      25. Cognitive reframing for carers of people with dementiaReview
      26. Cognitive stimulation to improve cognitive functioning in people with dementiaReview
      27. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementiaReview
      28. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyReview
      29. D-cycloserine for Alzheimer's diseaseReview
      30. Dehydroepiandrosterone (DHEA) supplementation for cognitive functionReviewWithdrawn
      31. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly peopleReview
      32. Donepezil for dementia due to Alzheimer's diseaseReview
      33. Donepezil for mild cognitive impairmentReview
      34. Donepezil for vascular cognitive impairmentReview
      35. Driving assessment for maintaining mobility and safety in drivers with dementiaReview
      36. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementiaReview
      37. Enteral tube feeding for older people with advanced dementiaReview
      38. Exercise programs for people with dementiaReview
      39. Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalusReview
      40. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented peopleReview
      41. Functional analysis-based interventions for challenging behaviour in dementiaReview
      42. Galantamine for Alzheimer's disease and mild cognitive impairmentReview
      43. Galantamine for vascular cognitive impairmentReview
      44. Ginkgo biloba for cognitive impairment and dementiaReview
      45. Ginseng for cognitionReview
      46. Haloperidol for agitation in dementiaReview
      47. Homeopathy for dementiaReview
      48. Hormone replacement therapy for cognitive function in postmenopausal womenReview
      49. Hormone replacement therapy to maintain cognitive function in women with dementiaReview
      50. Huperzine A for Alzheimer's diseaseReview
      51. Huperzine A for mild cognitive impairmentReview
      52. Huperzine A for vascular dementiaReview
      53. Hydergine for dementiaReview
      54. Hyperbaric oxygen therapy for vascular dementiaReview
      55. Ibuprofen for Alzheimer's diseaseReview
      56. Indomethacin for Alzheimer's diseaseReview
      57. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingReviewDiagnosticNew
      58. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsReviewDiagnostic
      59. Interventions for preventing and reducing the use of physical restraints in long-term geriatric careReview
      60. Interventions for preventing delirium in hospitalised patientsReview
      61. Interventions for preventing delirium in older people in institutional long-term careReview
      62. Lecithin for dementia and cognitive impairmentReview
      63. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementiaReview
      64. Massage and touch for dementiaReview
      65. Melatonin for the treatment of dementiaReview
      66. Memantine for dementiaReview
      67. Metal protein attenuating compounds for the treatment of Alzheimer's dementiaReview
      68. Metrifonate for Alzheimer's diseaseReview
      69. Multidisciplinary team interventions for delirium in patients with chronic cognitive impairmentReviewWithdrawn
      70. Music therapy for people with dementiaReview
      71. Naftidrofuryl for dementiaReview
      72. Nicergoline for dementia and other age associated forms of cognitive impairmentReview
      73. Nicotine for Alzheimer's diseaseReview
      74. Nimodipine for primary degenerative, mixed and vascular dementiaReview
      75. -Non-pharmacological interventions for wandering of people with dementia in the domestic settingReview
      76. Omega 3 fatty acid for the prevention of cognitive decline and dementiaReview
      77. Pharmacotherapies for sleep disturbances in Alzheimer's diseaseReview
      78. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairmentReview
      79. Physostigmine for dementia due to Alzheimer's diseaseReview
      80. Piracetam for dementia or cognitive impairmentReview
      81. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)ReviewDiagnostic
      82. Procaine treatments for cognition and dementiaReview
      83. Propentofylline for dementiaReview
      84. Psychological treatments for depression and anxiety in dementia and mild cognitive impairmentReview
      85. Psychosocial interventions for reducing antipsychotic medication in care home residentsReview
      86. Reality orientation for dementiaReviewWithdrawn
      87. Reminiscence therapy for dementiaReview
      88. Respite care for people with dementia and their carersReview
      89. Rivastigmine for Alzheimer's diseaseReview
      90. Rivastigmine for vascular cognitive impairmentReview
      91. Selegiline for Alzheimer's diseaseReview
      92. Shunting for normal pressure hydrocephalus (NPH)Review
      93. Snoezelen for dementiaReview
      94. Special care units for dementia individuals with behavioural problemsReview
      95. Statins for the prevention of dementiaReview
      96. Statins for the treatment of dementiaReviewNew Search
      97. Subjective barriers to prevent wandering of cognitively impaired peopleReview
      98. Support for carers of people with Alzheimer's type dementiaReviewWithdrawn
      99. Tacrine for Alzheimer's diseaseReviewWithdrawn
      100. Thiamine for Alzheimer's diseaseReview
      101. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcoholReview
      102. Thioridazine for dementiaReview
      103. Transcutaneous Electrical Nerve Stimulation (TENS) for dementiaReview
      104. Trazodone for agitation in dementiaReview
      105. Validation therapy for dementiaReview
      106. Valproate preparations for agitation in dementiaReview
      107. Velnacrine for Alzheimer's diseaseReview
      108. Vinpocetine for cognitive impairment and dementiaReview
      109. Vitamin B12 for cognitionReview
      110. Vitamin B6 for cognitionReview
      111. Vitamin E for Alzheimer's dementia and mild cognitive impairmentReview
      112. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementiaReview
      113. Yizhi capsule for vascular dementiaReview
      114. Zhiling decoction for vascular dementiaReview
    3. Protocols
      1. The accuracy of 18FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCIProtocolDiagnostic
      2. AD-8 for diagnosis of dementia across a variety of healthcare settingsProtocolDiagnostic
      3. Antibiotics and antivirals for dementia and mild cognitive impairmentProtocol
      4. APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingProtocolDiagnostic
      5. APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingProtocolDiagnostic
      6. APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care settingProtocolDiagnostic
      7. Art therapy for people with dementiaProtocol
      8. Assistive technology for memory support in dementiaProtocol
      9. Caffeine for cognitionProtocol
      10. Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD)Protocol
      11. Case/care management approaches to home support for people with dementiaProtocol
      12. Cerebrolysin for Alzheimer's diseaseProtocol
      13. Cholinesterase inhibitors for neurological conditions associated with rarer dementiasProtocol
      14. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)ProtocolDiagnostic
      15. Dance movement therapy for dementiaProtocol
      16. Dimebon for Alzheimer's diseaseProtocol
      17. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodiesProtocolDiagnostic
      18. Educational interventions for improving the skills of medical practitioners to detect, diagnose, and manage people with cognitive impairment and dementiaProtocol
      19. Effectiveness of post-operative management strategies for adults with dementia following hip fracture surgeryProtocol
      20. Efficacy and experiences of telephone counselling for informal carers of people with dementiaProtocol
      21. Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH)Protocol
      22. Ginkgo biloba for cognitive improvement in healthy individualsProtocol
      23. Information and support interventions for informal caregivers of people with dementiaProtocol
      24. IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingProtocolDiagnostic
      25. L-carnitine for cognition in healthy subjectsProtocol
      26. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingProtocolDiagnostic
      27. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s dementia and other dementias in asymptomatic and previously clinically unevaluated people aged over 65 years in community and primary care populationsProtocolDiagnostic
      28. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)ProtocolDiagnostic
      29. Modifying the consistency of food and fluids for swallowing difficulties in dementiaProtocol
      30. The Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementia disordersProtocolDiagnostic
      31. Multidisciplinary Team Interventions for the management of delirium in hospitalized patientsProtocol
      32. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesProtocolDiagnostic
      33. Omega 3 fatty acids for the treatment of dementia and cognitive impairmentProtocol
      34. Opioids for agitation in dementiaProtocol
      35. Passive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer's diseaseProtocol
      36. Personally-tailored activities for improving psychosocial outcomes for people with dementia in community settingsProtocol
      37. Personally-tailored activities for improving psychosocial outcomes for people with dementia in long-term careProtocol
      38. Pharmacotherapy for chronic cognitive impairment in traumatic brain injuryProtocol
      39. Physical activity for improving cognition in older people with mild cognitive impairmentProtocol
      40. Plasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingProtocolDiagnostic
      41. Posatirelin (l-pyro-2-aminoadipyl-l-leucyl-l-prolinamide) treatment for persons with dementiaProtocol
      42. rCBF SPECT for detection of frontotemporal dementia in people with suspected dementiaProtocolDiagnostic
      43. The role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)ProtocolDiagnostic
      44. Testosterone supplementation for mild cognitive impairment and dementiaProtocol
      45. Thiazolidinediones for dementia and mild cognitive impairmentProtocol
      46. Traditional Chinese herbal medicine for vascular dementiaProtocol
      47. Tramiprosate (Alzhemed) for Alzheimer's diseaseProtocol
      48. Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia.Protocol
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH